IMO, it is hard to determine what is and is not factored into the CSL share price. For instance, here are some factors driving the CSL share price
a) AUD /USD exchange rate
b) market share growth and market size growth
c) Seqirus turnaround
d) CSL 112
e) China expansion
f) Growth in Specialty drugs
g) R & D pipeline
h) Growth in Plasma collection centres
i) Calimmune Stem Cell work
j) Excellent management team
k) Brian Macnamee as Chairman
I know that I do not have the skill to do a "sum of the parts" valuation and weigh all the growth drivers for the business. All I know is that I am very very very reluctant to ever want to sell.
HT1
IMO, it is hard to determine what is and is not factored into...
-
- There are more pages in this discussion • 248 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$292.60 |
Change
-2.610(0.88%) |
Mkt cap ! $141.3B | |||
| Open | High | Low | Value | Volume |
| $293.17 | $293.93 | $291.50 | $177.3M | 606.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1768 | $292.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $292.65 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |